HALO logo
halo search icon
SOBI
Swedish Orphan Biovitrum AB

SOBI · Swedish Orphan Biovitrum AB

444.80

SEK
4.60 (1.04%)
22/06/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

kr166.70B

PE

240.70

EV/EBITDA

10.9

DIV Yield

0%

Payout Ratio

0%

MQV Rating

5Very Weak

As at 22/06/2026 12:00:00 AM

Price Chart

Description

Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes in the treatment of genetic and metabolic diseases. The company was founded in 2001 and is headquartered in Solna, Sweden.

  • All-Companies
  • All-Consensus
  • Engulfing Bullish
  • Near 52 Week High
  • Near Resistance
  • Near Resistance (Realtime)

Key Fundamentals

EPS 3 yr Growth

-83.80%

EBITDA Margin

40.90%

Operating Cashflow

kr8,566m

Free Cash Flow Return

17.80%

ROIC

1.00%

Interest Coverage

14.20

Quick Ratio

0.60

Performance

52 weeks range

Low 261.2 - 466.4

Trade Value (12mth)

US$3,545,780.00

1 week

1.28%

1 month

0.77%

YTD

34.62%

1 year

63.17%

All time high

451.80

Additional Data

Shares Outstanding (Fully Diluted)

349m

HALO Sector

Healthcare

Next Company Report Date

04-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

SEK

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
The current share price of Swedish Orphan Biovitrum AB (SOBI:OME) is SEKkr444.80.
2
What is the 52-week high share price for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
The 52-week high share price for Swedish Orphan Biovitrum AB (SOBI:OME) is SEKkr466.40.
3
What is the 52-week low share price for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
The 52-week low share price for Swedish Orphan Biovitrum AB (SOBI:OME) is SEKkr261.20.
4
What is the dividend yield for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
Swedish Orphan Biovitrum AB (SOBI:OME) does not pay a dividend.
5
What was Swedish Orphan Biovitrum AB (SOBI:OME) last dividend payment?
Halo FAQ
Swedish Orphan Biovitrum AB (SOBI:OME) does not pay a dividend.
6
What is the franking level for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
Swedish Orphan Biovitrum AB (SOBI:OME) has a franking level of 0.00%.
7
In which sector is Swedish Orphan Biovitrum AB (SOBI:OME) classified?
Halo FAQ
Swedish Orphan Biovitrum AB (SOBI:OME) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for Swedish Orphan Biovitrum AB (SOBI:OME)?
Halo FAQ
The current P/E ratio for Swedish Orphan Biovitrum AB (SOBI:OME) is 240.70.